Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

EMA committee recommends approval of Novartis's multiple myeloma drug Farydak The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Swiss drugmaker Novartis's Farydak (panobinostat) to treat patients with multiple myeloma. Production & Manufacturing > Process & Production > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

FDA accepts to review Pfizer's NDA for rheumatoid arthritis drug Xeljanz
By PBR Staff Writer
The US Food and Drug Administration (FDA) has accepted to review Pfizer’s new drug application (NDA) for Xeljanz (tofacitinib citrate) 11mg once daily modified release tablets to treat moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or intolerance to methotrexate (MTX).
Production & Manufacturing > Process & Production > News
Boehringer's Spiolto Respimat approved in European countries to treat COPD
By PBR Staff Writer
Boehringer Ingelheim has received regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in European countries as a once-daily maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
Production & Manufacturing > Process & Production > News

OTC

Nutra Pharma selects Pickwick Capital Partners for strategic advisory services
Nutra Pharma, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced that they have engaged Pickwick Capital Partners; a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services.
Production & Manufacturing > OTC > News
Medical Marijuana holds investment in AXIM Biotechnologies
Medical Marijuana would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (AXIM), a cutting-edge biotechnology innovator.
Production & Manufacturing > OTC > News

Manufacturing

Teva launches generic Aggrenox capsules in US
Teva Pharmaceutical Industries has launched generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States.
Production & Manufacturing > Manufacturing > News
Medicines Patent Pool expands generic manufacturing network to ramp-pp low cost ARVs production
The Medicines Patent Pool (MPP) announced the rapid expansion of its network of generic manufacturers to 14 companies now working on more than 50 projects to develop MPP-licensed antiretrovirals (ARVs).
Production & Manufacturing > Manufacturing > News